Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

Press releases published on April 28, 2026

Apr. 28, 2026

ExamWorks Announces Appointment of Isabelle Winkles as Chief Financial Officer to Support Continued Growth and Strategic Execution

Indeterminate GlobeNewswire

Apr. 28, 2026

VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing

Indeterminate GlobeNewswire

Apr. 28, 2026

Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

Indeterminate GlobeNewswire

Apr. 28, 2026

Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States

Indeterminate GlobeNewswire

Apr. 28, 2026

Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis

Indeterminate GlobeNewswire

Apr. 28, 2026

Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics

Indeterminate GlobeNewswire

Apr. 28, 2026

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

Indeterminate GlobeNewswire

Apr. 28, 2026

Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results

Indeterminate GlobeNewswire

Apr. 28, 2026

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

Indeterminate GlobeNewswire

Apr. 28, 2026

Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment

Indeterminate GlobeNewswire

Apr. 28, 2026

Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand

Indeterminate GlobeNewswire

Apr. 28, 2026

CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation

Indeterminate GlobeNewswire

Apr. 28, 2026

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Apr. 28, 2026

Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies

Indeterminate GlobeNewswire

Apr. 28, 2026

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

Indeterminate GlobeNewswire

Apr. 28, 2026

Nautilus Biotechnology Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Apr. 28, 2026

BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures

Indeterminate GlobeNewswire

Apr. 28, 2026

Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio

Indeterminate GlobeNewswire

Apr. 28, 2026

Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology

Indeterminate GlobeNewswire

Apr. 28, 2026

Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time

Indeterminate GlobeNewswire